Molecular Tumor Board: 65-year-old male with recurrent hepatocellular carcinoma

This molecular tumor board where we present a case of recurrent hepatocellular carcinoma (HCC) with interesting immune phenotypes discovered on a comprehensive genomic and immune profiling test. We reviewed TIGIT as a promising target for cancer immunotherapy and outlined the prognosis and treatment paradigm of HCC along with discussing the different stages and potential barriers of clinical trial enrollment.

Read more »
<span>Supporting customer success through powerful sample logistics and a global central lab network</span>
March 27, 2024

Supporting customer success through powerful sample logistics and a global central lab network

A leading Japanese pharmaceutical company chose to partner with Labcorp to provide central laboratory testing services for a complex regional clinical trial. Their flow cytometry (FCM) panel for immunology was planned for a duration of three to four years. The primary challenges were the short stability period (48 hours) of trial samples and the fact that all the trial locations were not yet determined. Labcorp’s efficient logistics enabled speedy shipping for reliable data. By leveraging its worldwide network of accredited central lab facilities that use standardized assays and procedures, Labcorp gave the client the flexibility to conduct trials wherever needed, while ensuring consistent and reliable data that was also combinable.
Read more »